Elranatamab, a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, for patients (pts) with relapsed/refractory multiple myeloma (RRMM): Extended follow up and biweekly administration from the MagnetisMM-3 study
Mohty, Mohamad, Tomasson, Michael H., Arnulf, Bertrand, Bahlis, Nizar J., Prince, H. Miles, Niesvizky, Ruben, Rodríguez-Otero, Paula, Martinez-Lopez, Joaquin, Koehne, Guenther, Jethava, Yogesh, Gabayan, A. Eli, Stevens, Don A., Nooka, Ajay K., Raje, Noopur S., Iida, Shinsuke, Leip, Eric, Conte, Umberto, Czibere, Akos Gabor, Viqueira, Andrea, Lesokhin, Alexander M.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Clinical and safety outcomes of TALAPRO-2: A two-part phase III study of talazoparib (TALA) in combination with enzalutamide (ENZA) in metastatic castration-resistant prostate cancer (mCRPC)
Agarwal, Neeraj, Shore, Neal D., Dunshee, Curtis, Karsh, Lawrence Ivan, Sullivan, Beth, Di Santo, Nicola, Elmeliegy, Mohamed, Lin, Xun, Czibere, Akos Gabor, Fizazi, Karim
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
TALAPRO-2: Part 2 (P2) of the placebo-controlled phase 3 study of talazoparib (TALA) with enzalutamide (ENZA) in metastatic castration-resistant prostate cancer (mCRPC)
Agarwal, Neeraj, Shore, Neal D., Dunshee, Curtis, Karsh, Lawrence Ivan, Sullivan, Beth, Di Santo, Nicola, Elmeliegy, Mohamed, Lin, Xun, Quek, Ruben G.W., Czibere, Akos Gabor, Fizazi, Karim
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Efficacy and safety of talazoparib (TALA) or physician's choice of therapy (PCT) in United States patients (pts) with HER2- germline BRCA1/2-mutated (gBRCAm) locally advanced/metastatic breast cancer (LA/MBC) in the EMBRACA study
Diab, Sami, Rugo, Hope S., Mina, Lida A., Puhalla, Shannon, Mahtani, Reshma L., Henry, Norah Lynn, Denduluri, Neelima, Yardley, Denise A., Wang, Yao, Arruda, Lillian Shahied, Tudor, Iulia Cristina, Gauthier, Eric Roland, Czibere, Akos Gabor, Litton, Jennifer Keating, Hurvitz, Sara A.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Outcomes of talazoparib (TALA) versus physician's choice of chemotherapy (PCT) in patients (pts) with advanced breast cancer (ABC) and a germline BRCA (gBRCA) mutation by line of chemotherapy (CT) in the EMBRACA trial
Ettl, Johannes, Hurvitz, Sara A., Rugo, Hope S., Lee, Kyung-Hun, Mina, Lida A., Woodward, Natasha E., Yerushalmi, Rinat, Diab, Sami, Martin, Miguel, Tudor, Iulia Cristina, Czibere, Akos Gabor, Gauthier, Eric Roland, Litton, Jennifer Keating, Goncalves, Anthony
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
First-in-human study of MM-141: A novel tetravalent monoclonal antibody targeting IGF-1R and ErbB3
Isakoff, Steven J., Saleh, Mansoor N., Lugovskoy, Alexey, Manoli, Sara, Czibere, Akos Gabor, LoRusso, Patricia, Arnedos, Monica
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
A phase 2 study of seribantumab (MM-121) in combination with docetaxel or pemetrexed versus docetaxel or pemetrexed alone in patients with heregulin positive (HRG+), locally advanced or metastatic non-small cell lung cancer (NSCLC)
Sequist, Lecia V., Anderson, Ian Churchill, Demars, Nathan, Felip, Enriqueta, Harb, Wael A., Huber, Rudolf M., Kudla, Art J., Lee, Jean Kyung, Mathews, Sara, McClure, Ty, Nieva, Jorge J., Perol, Maurice, Shepherd, Frances A., Spira, Alexander I., Czibere, Akos Gabor
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
First-in-human study of MM-141: A novel tetravalent monoclonal antibody targeting IGF-1R and ErbB3
Isakoff, Steven J., Saleh, Mansoor N., Lugovskoy, Alexey, Mathews, Sara, Czibere, Akos Gabor, Shields, Anthony Frank, Bahleda, Rastislav, Soria, Jean-Charles, Arnedos, Monica
Published in Journal of clinical oncology (20.01.2015)
Published in Journal of clinical oncology (20.01.2015)
Get full text
Journal Article
Effect of MM-141 on gemcitabine and nab-paclitaxel potentiation in preclinical models of pancreatic cancer through induction of IGF-1R and ErbB3 degradation
Pace, Emily, Adams, Sharlene, Camblin, Adam, Curley, Michael, Rimkunas, Victoria, Nie, Lin, Iadevaia, Sergio, Tan, Gege, Baum, Jason, Czibere, Akos Gabor, Lugovskoy, Alexey
Published in Journal of clinical oncology (20.01.2015)
Published in Journal of clinical oncology (20.01.2015)
Get full text
Journal Article
HER3 as a potential prognostic biomarker in pancreatic cancer
Wang-Gillam, Andrea, Rimkunas, Victoria, Abu-Yousif, Adnan, Nywening, Timothy M., Gao, Feng, DeNardo, David G, Linehan, David, Czibere, Akos Gabor, Lugovskoy, Alexey
Published in Journal of clinical oncology (20.01.2015)
Published in Journal of clinical oncology (20.01.2015)
Get full text
Journal Article
Randomized phase 2 study of paclitaxel (PTX), trastuzumab (T) with or without MM-111 in HER2 expressing gastroesophageal cancers (GEC)
Denlinger, Crystal Shereen, Alsina Maqueda, Maria, Watkins, David J., Sym, Sun Jin, Bendell, Johanna C., Park, Se Hoon, Arkenau, Hendrik-Tobias, Bekaii-Saab, Tanios S., Kudla, Art J., McDonagh, Charlotte Fenton, Czibere, Akos Gabor, Chibaudel, Benoist, Press, Michael F., Yoon, Harry H., Hecht, J. Randolph, Cunningham, David, Bang, Yung-Jue
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
A phase I study of MM-121 in combination with multiple anticancer therapies in patients with advanced solid tumors
Arnedos, Monica, Denlinger, Crystal Shereen, Harb, Wael A., Rixe, Olivier, Morris, John Charles, Dy, Grace K., Adjei, Alex A., Pearlberg, Joseph, Follows, Sarah, Czibere, Akos Gabor, Soria, Jean-Charles
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
A randomized phase 2 trial of MM-121, a fully human monoclonal antibody targeting ErbB3, in combination with erlotinib in EGFR wild-type NSCLC patients
Sequist, Lecia V., Lopez-Chavez, Ariel, Doebele, Robert Charles, Gray, Jhanelle Elaine, Harb, Wael A., Modiano, Manuel R., Jackman, David Michael, Baggstrom, Maria Quintos, Atmaca, Akin, Felip, Enriqueta, Provencio, Mariano, Cobo, Manuel, Kripas, Christopher J., MacBeath, Gavin, Czibere, Akos Gabor, Cho, Byoung Chul, Park, Keunchil, Shepherd, Frances A.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
A phase II randomized open-label study of MM-121, a fully human monoclonal antibody targeting ErbB3, in combination with weekly paclitaxel versus weekly paclitaxel in patients with platinum-resistant/refractory ovarian cancers
Liu, Joyce, Ray-Coquard, Isabelle Laure, Selle, Frédéric, Poveda, Andres, Cibula, David, Hirte, Hal W., Raspagliesi, Francesco, Gladieff, Laurence, Harter, Philipp, Schiavetto, Ilaria, Tabah-Fisch, Isabelle Marie, MacBeath, Gavin, Czibere, Akos Gabor, Naumann, R. Wendel, Coleman, Robert L., Vergote, Ignace, Pujade-Lauraine, Eric
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Randomized open-label phase 2 study of MM-111 and paclitaxel (PTX) with trastuzumab (TRAS) in patients with HER2-expressing carcinomas of the distal esophagus, gastroesophageal (GE) junction, and stomach who have failed front-line metastatic or locally advanced therapy
Denlinger, Crystal Shereen, Sym, Sun Jin, Bendell, Johanna C., Alsina, Maria, Watkins, David, Chao, Yee, Cubillo, Antonio, Kunz, Pamela L., Sun, Weijing, Baeksgaard, Lene, Chen, Li-Tzong, Horgan, Kerry, Frye, Sasha, Kudla, Arthur J., McDonagh, Charlotte Fenton, Czibere, Akos Gabor, Moyo, Victor M., Chibaudel, Benoist, Bang, Yung-Jue
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Azacitidine (Vidaza®, Aza) and Donor Lymphocyte Infusions (DLI) In Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Interim-Analysis From the AZARELA-Trial (NCT-00795548)
Schroeder, Thomas, Czibere, Akos Gabor, Kröger, Nicolaus, Platzbecker, Uwe, Bug, Gesine, Rieger, Kathrin, Luft, Thomas, Bruns, Ingmar, Zohren, Fabian, Wolschke, Christine, Fenk, Roland, Haas, Rainer, Kobbe, Guido
Published in Blood (19.11.2010)
Published in Blood (19.11.2010)
Get full text
Journal Article